Observational Study to Evaluate the Quality of Life of Healthy Postmenopausal Women Who Take Coenzyme Q-Ubiquinol

Dr. Santiago Palacios40 enrolled

Overview

Observational study about quality of life in postmenopausal women taking coenzyme Q compared to another group of women of the same age who do not take it

Observational study to evaluate the subjective assessment performed by healthy postmenopausal women who are taking coenzyme Q for 3 months, compared with other groups of the same characteristics that do not take it

Study Type

OBSERVATIONAL

Enrollment

Conditions

Health Status

Interventions

Coenzima Q - QubiquinolCoenzyme Q - QubiquinolDIETARY_SUPPLEMENT

Patients in the active group will take one tablet a day orally

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Postmenopausal woman between 45 and 65 years old * Woman who is taking coenzyme Q-Ubiquinol and who will continue taking at least the next 3 months * Woman not taking Coenzyme Q-Ubiquinol and not going to take it in the next 3 months Exclusión Criteria: * Patients with severe mental illness. * Suspicion or abuse of alcohol or other drugs during the 12 months prior to the selection * Any other consideration or finding that, in the opinion of the investigator, considers the non-participation of the subject in the study.

Locations (1)

Instituto Palacios

Madrid, Spain

Outcomes

Primary Outcomes

Change from Baseline Quality of Life at 3 months

To evaluate the quality of life in healthy postmenopausal women who are taking Coenzyme Q-Ubiquinol for 3 months in comparison with another group that does not take them. The Cervantes Health-Related Quality of Life scale for menopause will be used for this outcome. In that scale next to the 0 and the 5 there are words that describe two opposite answers to the question. Between the 0 and the 5 there are also four boxes numbered 1 to 4. The participants should answer the questions by checking the box that best represents what they think and feel. In other words, they should check 5 if they are completely agree and 0 they are completely disagree. If they are not completely agree or disagree, they should check the boxes in between

Time frame: Baseline and 3 months

Secondary Outcomes

Change from Baseline General Health at 3 months

Health Scale Euroqol EQ-5D will be used for this outcome

Time frame: Baseline and 3 months

Change from Baseline Mood at three months

An analogic scale will be used for this outcome in wich 0 points is the best mood and 10 points is worst mood

Time frame: Baseline and 3 months

Change from Baseline Cramps at three months

To assess changes in cramps in patients who had them, a general questionnaire about Cramps will be used to assess mainly the intensity and frequency of crambs. Regarding the intensity 0 is the lower pain and 10 is the worst pain

Time frame: Baseline and 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.